Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Abbott Laboratories buy Piper Sandler

Start price
€103.70
19.09.24 / 50%
Target price
€117.72
19.09.25
Performance (%)
12.09%
End price
€116.24
20.09.25
Summary
This prediction ended on 20.09.25 with a price of €116.24. The prediction had a final performance of 12.09%. Piper_Sandler has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Dividends of €1.08 are taken into consideration when calculating the performance. Piper_Sandler has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Abbott Laboratories 4.194% 4.194% 1.203%
iShares Core DAX® 0.795% 1.458% 17.980%
iShares Nasdaq 100 -3.088% -0.762% 3.169%
iShares Nikkei 225® -0.952% -2.268% 12.208%
iShares S&P 500 -1.393% 0.199% 1.698%

Comments by Piper_Sandler for this prediction

In the thread Discuss Abbott Laboratories
Prediction Buy
Perf. (%) 12.09%
Target price 117.717
Change
Ends at 19.09.25

Abbott Laboratories (NYSE: ABT) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $131.00 price target on the stock.
Ratings data for ABT provided by MarketBeat

In the thread Trading Abbott Laboratories
Prediction Buy
Perf. (%) 12.09%
Target price 117.717
Change
Ends at 19.09.25

Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten

Current prediction by Piper_Sandler for Abbott Laboratories

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€116.00
17.04.25
€127.60
17.04.26
-5.76%
15.12.25

Stopped prediction by Piper_Sandler for Abbott Laboratories

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€109.48
17.10.24
€122.61
17.10.25
0.46%
18.10.25